What is DiaMedica Therapeutics Inc. Common Stock's Market Cap?

DiaMedica Therapeutics Inc. Common Stock's Market Cap is $352.7M, based on as-reported figures from SEC (XBRL) filings.

What is DiaMedica Therapeutics Inc. Common Stock's Enterprise Value?

DiaMedica Therapeutics Inc. Common Stock's Enterprise Value is $309.2M, based on as-reported figures from SEC (XBRL) filings.

What is DiaMedica Therapeutics Inc. Common Stock's EV / EBITDA?

DiaMedica Therapeutics Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is DiaMedica Therapeutics Inc. Common Stock's Net Income (TTM)?

DiaMedica Therapeutics Inc. Common Stock's Net Income (TTM) is -$37.5M, based on as-reported figures from SEC (XBRL) filings.

What is DiaMedica Therapeutics Inc. Common Stock's EBITDA?

DiaMedica Therapeutics Inc. Common Stock's EBITDA is -$39.2M, based on as-reported figures from SEC (XBRL) filings.

What is DiaMedica Therapeutics Inc. Common Stock's Diluted EPS (TTM)?

DiaMedica Therapeutics Inc. Common Stock's Diluted EPS (TTM) is -0.70, based on as-reported figures from SEC (XBRL) filings.

What is DiaMedica Therapeutics Inc. Common Stock's Net Debt?

DiaMedica Therapeutics Inc. Common Stock's Net Debt is -$43.5M, based on as-reported figures from SEC (XBRL) filings.

DiaMedica Therapeutics Inc. Common Stock (DMAC) Financial Statements

DiaMedica Therapeutics Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001SQ3K65

XNAS · usd

6.54▼ 0.21 (-3.11%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close6.75

Day's Range6.53 – 6.71

52-Week Range5.25 – 10.42

Volume118.7K

Avg Volume144.3K

Share Statistics

Shares Outstanding

Employees35

ExchangeXNAS

Listed2007-11-29

Share count as of August 3, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about DiaMedica Therapeutics Inc. Common Stock (DMAC)

What is DiaMedica Therapeutics Inc. Common Stock's Market Cap?: DiaMedica Therapeutics Inc. Common Stock's Market Cap is $352.7M, based on as-reported figures from SEC (XBRL) filings.
What is DiaMedica Therapeutics Inc. Common Stock's Enterprise Value?: DiaMedica Therapeutics Inc. Common Stock's Enterprise Value is $309.2M, based on as-reported figures from SEC (XBRL) filings.
What is DiaMedica Therapeutics Inc. Common Stock's EV / EBITDA?: DiaMedica Therapeutics Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is DiaMedica Therapeutics Inc. Common Stock's Net Income (TTM)?: DiaMedica Therapeutics Inc. Common Stock's Net Income (TTM) is -$37.5M, based on as-reported figures from SEC (XBRL) filings.
What is DiaMedica Therapeutics Inc. Common Stock's EBITDA?: DiaMedica Therapeutics Inc. Common Stock's EBITDA is -$39.2M, based on as-reported figures from SEC (XBRL) filings.
What is DiaMedica Therapeutics Inc. Common Stock's Diluted EPS (TTM)?: DiaMedica Therapeutics Inc. Common Stock's Diluted EPS (TTM) is -0.70, based on as-reported figures from SEC (XBRL) filings.
What is DiaMedica Therapeutics Inc. Common Stock's Net Debt?: DiaMedica Therapeutics Inc. Common Stock's Net Debt is -$43.5M, based on as-reported figures from SEC (XBRL) filings.